The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism

dc.contributor.authorUnluhizarci, Kursad
dc.contributor.authorKula, Mustafa
dc.contributor.authorDundar, Munis
dc.contributor.authorTanriverdi, Fatih
dc.contributor.authorIsrael, Shoshana
dc.contributor.authorColak, Ramis
dc.contributor.authorKelestimur, Fahrettin
dc.date.accessioned2026-08-12T17:14:12Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstractThe prevalence of non-classic adrenal hyperplasia (NCAH) among Turkish women with hirsutism has not been established so far. Thus, we aimed to evaluate the prevalence of 21-hydroxylase (21-OH) deficiency by ACTH stimulation test among hirsute women. The study population consisted of 285 premenopousal women, aged 16-46 years (mean: 23.2 +/- 0.3). All were hirsute and hyperandrogenic. Androgen secreting tumors of the ovaries and the adrenal glands were excluded as well as thyroid dysfunction and hyperprolactinemia. All the patients were evaluated by 0.25 mg (i.v.) ACTH stimulation test and 17-OHP responses were obtained at 30 and 60 min. The diagnosis of NCAH due to 21-OH deficiency was considered in patients with the poststimulation 17-OHP level exceed 10 ng/ml. Six (2.1%) of the patients had NCAH due to 21-OH deficiency confirmed by genotyping. The rest of the patients were polycystic ovary syndrome (n = 166, 58.2%) and idiopathic hyperandrogenemia (n = 113, 39.7%). There were no patients with idiopathic hirsutism because patients with normal serum androgen levels were excluded. This first and most extensive national study investigating NCAH prevalence among Turkish population showed that NCAH is not prevalent in this population.
dc.description.sponsorshipThe Scientific and Technical Research Council of Turkey, TUBITAK [SBAG-3170]
dc.description.sponsorshipThis study was supported by The Scientific and Technical Research Council of Turkey, TUBITAK, (SBAG-3170).
dc.identifier.doi10.3109/09513590903215466
dc.identifier.endpage143
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.issue2
dc.identifier.orcid0000-0003-0300-4173
dc.identifier.orcid0000-0003-0969-4611
dc.identifier.orcid0000-0002-6494-3249
dc.identifier.orcid0000-0003-4150-6262
dc.identifier.pmid19718570
dc.identifier.scopus2-s2.0-75449100122
dc.identifier.scopusqualityQ2
dc.identifier.startpage139
dc.identifier.urihttps://doi.org/10.3109/09513590903215466
dc.identifier.urihttps://hdl.handle.net/11508/51733
dc.identifier.volume26
dc.identifier.wosWOS:000274578300015
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofGynecological Endocrinology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAdrenal hyperplasia
dc.subjecthirsutism
dc.subjectpolycystic ovary syndrome
dc.titleThe prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism
dc.typeArticle

Dosyalar